Does Cartalax really work?

There’s no human evidence that Cartalax works for any health purpose. It’s a synthetic tripeptide, Ala-Glu-Asp (AED), from the bioregulator group developed by Vladimir Khavinson’s lab in Russia. Published work is preclinical and mostly from that group, which reported that short peptides like AED changed the expression of aging-related genes in cultured cells, including human mesenchymal stem cells.

The proposed mechanism, short peptides binding DNA in gene promoters, hasn’t been widely tested by independent labs. Claims that Cartalax regenerates cartilage or relieves joint pain come from vendors, not controlled trials or independent studies. It’s best treated as a research tool for gene expression and cell aging studies in culture. Read our research purposes only policy. Shop Cartalax for your lab.